| Home |
| Site Map |
| News Archives |
| Environmental Health News |
| Illness Research |
| Articles |
| Treatment Information |
| Useful Lab Tests |
| Find A Doctor |
| Chemical Avoidance |
| Allergen Reduction |
| Water Filtration |
| Treatments & Products |
| Books |
| Dr. Teitelbaum's Column |
| Gloria Gilbčre's Column |
| Sick Building Syndrome |
| Seasonal Affective Disorder |
| Lyme Disease |
| Lupus |
| Hypoglycemia |
| Electrical Sensitivity |
| Adrenal Fatigue |
| Hypothyroidism |
| Sleep Apnea |
| Restless Leg Syndrome |
| Celiac Disease |
| Water Filters |
| SAD Light Boxes |
| Hepa Air Purifiers |
| HEPA Vacuum Cleaners |
| Nutritional Supplements |
| Home Test Kits |
| Cleaning Products |
| Personal Care |
| LifeWave Patches |
|
|
| Research - Candida & Gut Dysbiosis Research | |
|
Am J Clin Nutr. 2008 May;87(5):1365-73.
Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial.
Chouraqui JP, Grathwohl D, Labaune JM, Hascoet JM, de Montgolfier I, Leclaire M, Giarre M, Steenhout P. Gastroenterology and Nutrition Unit, Department of Pediatrics, Centre Hospitalier Universitaire de Grenoble, Grenoble, France. This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
BACKGROUND: Probiotics and prebiotics are considered to be beneficial to the gastrointestinal health of infants.
OBJECTIVE: The objective was to evaluate infant formulas containing probiotics and synbiotics (combinations of probiotics and prebiotics) for safety and tolerance.
DESIGN: In a prospective, controlled, double-blind, randomized trial, healthy full-term infants were exclusively fed a control formula or study formulas containing Bifidobacterium longum BL999 (BL999) + Lactobacillus rhamnosus LPR (LPR), BL999 + LPR + 4 g/L of 90% galactooligosaccharide/10% short-chain fructooligosaccharide (GOS/SCFOS), or BL999 + Lactobacillus paracasei ST11 (ST11) + 4 g/L GOS/SCFOS from < or = 2 to 16 wk of age (treatment period). Safety and tolerance were assessed based on weight gain during the treatment period (primary outcome) as well as recumbent length, head circumference, digestive tolerance, and adverse events (secondary outcomes), which were evaluated at 2, 4, 8, 12, 16, and 52 wk of age.
RESULTS: Two hundred eighty-four infants were enrolled. During the treatment period, difference in mean weight gain between control and study formula groups in both the intention-to-treat and per-protocol populations were within the predefined equivalence boundaries of +/-3.9 g/d, indicating equivalent weight gain. Secondary outcomes did not show significant differences between groups during the treatment period.
CONCLUSION: Infants fed formulas containing probiotics or synbiotics show a similar rate in weight gain compared with those fed a control formula and tolerate these formulas well.
Comments (0)
![]() Write comment
Discuss this article on the forums. (0 posts) |
|
| < Prev | Next > |
|---|
| searching for a doctor marie olene 11-12-08 23:42 |
| Skin Lesions Granuloma annulare Humminbyrd 11-05-08 20:39 |
| headaches, vertigo karenk 11-01-08 16:07 |
| All Canadians with MCS... LadyItchalot 10-20-08 04:42 |
| Skincare for those with Chemical Sensit... yayaba08 10-14-08 19:28 |
Subscribe to our newsletter and receive regular updates of our latest content: